Drug Type T cell engagers (TCE) |
Synonyms DBXO 4, DBXO4 |
Target |
Action stimulants, modulators |
Mechanism CD3 stimulants(T cell surface glycoprotein CD3 stimulants), HLA-A modulators(major histocompatibility complex, class I, A modulators) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization |
Active Organization- |
Inactive Organization- |
License Organization- |
Drug Highest Phase- |
First Approval Date- |
Regulation- |






